Rosaria De Filippi Selected Research

Rosaria De Filippi Research Topics

Disease

11	Neoplasms (Cancer) 12/2021 - 10/2003
7	Hodgkin Disease (Hodgkin's Disease) 12/2021 - 09/2009
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2012 - 08/2006
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2022
1	Residual Neoplasm 04/2022
1	Overweight 12/2021
1	COVID-19 06/2021
1	Severe Acute Respiratory Syndrome 06/2021
1	Infections 06/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2021
1	Disease Progression 06/2021
1	Leukemia 02/2021
1	Lymphoma (Lymphomas) 02/2021
1	Meningitis 02/2021
1	Primitive Neuroectodermal Tumors (PNET) 10/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2011
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2011
1	Carcinoma (Carcinomatosis) 08/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2009
1	Lymphocytosis 09/2007
1	Heart Failure 08/2006
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2006
1	Sepsis (Septicemia) 08/2006
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 08/2006

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 06/2021 - 08/2006
2	LigandsIBA 12/2021 - 08/2011
2	Biomarkers (Surrogate Marker)IBA 02/2021 - 01/2019
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2021 - 01/2012
2	Biological ProductsIBA 01/2019 - 12/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2014 - 09/2011
2	Lenalidomide (CC 5013)FDA Link 03/2012 - 01/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2011 - 10/2003
1	NivolumabIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	VaccinesIBA 07/2021
1	AntibodiesIBA 06/2021
1	Immunoglobulin G (IgG)IBA 06/2021
1	Immunoglobulin M (IgM)IBA 06/2021
1	RNA (Ribonucleic Acid)IBA 06/2021
1	Viral RNAIBA 06/2021
1	Arabinofuranosylcytosine TriphosphateIBA 02/2021
1	pyrimidineIBA 02/2021
1	NucleosidesIBA 02/2021
1	EnzymesIBA 02/2021
1	Pharmaceutical PreparationsIBA 01/2019
1	AntigensIBA 12/2016
1	Peptides (Polypeptides)IBA 12/2016
1	Dacarbazine (DIC)FDA LinkGeneric 07/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2014
1	Vinblastine (Vinblastine Sulfate)FDA Link 07/2014
1	Bendamustine Hydrochloride FDA Link 01/2013
1	fotemustine (Muphoran)IBA 12/2011
1	Vincristine (Oncovin)FDA LinkGeneric 09/2011
1	Liposomes (Liposome)IBA 09/2011
1	Prednisone (Sone)FDA LinkGeneric 09/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2011
1	ErbB Receptors (EGF Receptor)IBA 08/2011
1	Otx Transcription FactorsIBA 12/2009
1	TNF Receptor-Associated Factor 1IBA 10/2009
1	Interleukin-6 (Interleukin 6)IBA 09/2009
1	Interleukin-7 (Interleukin 7)IBA 09/2009
1	ChemokinesIBA 09/2009
1	InterleukinsIBA 09/2009
1	CytokinesIBA 09/2009
1	Hemoglobins (Hemoglobin)IBA 09/2007
1	TransferasesIBA 08/2006
1	SteroidsIBA 08/2006
1	Monoclonal AntibodiesIBA 08/2006

Therapy/Procedure

4	Therapeutics 02/2021 - 08/2006
3	Immunotherapy 12/2021 - 10/2003
2	Drug Therapy (Chemotherapy) 02/2021 - 10/2003
2	Radiotherapy 07/2014 - 10/2003
1	Radioimmunotherapy 04/2022
1	Aftercare (After-Treatment) 04/2022
1	Stem Cell Transplantation 01/2013